New Legal Action Filed in Maryland: Healthcare Living for Families, Inc. vs. Optum, Inc. et al.,govinfo.gov District CourtDistrict of Maryland


New Legal Action Filed in Maryland: Healthcare Living for Families, Inc. vs. Optum, Inc. et al.

A new legal case, Healthcare Living for Families, Inc. v. Optum, Inc. et al., has been formally filed in the U.S. District Court for the District of Maryland, as publicly recorded on govinfo.gov. The filing, designated as case number 1:25-cv-00079, was published on August 9, 2025, at 23:39.

While the specifics of the allegations and the nature of the dispute are not detailed in the initial public record, the naming of the parties suggests a matter involving significant entities within the healthcare sector. Healthcare Living for Families, Inc. appears as the plaintiff, initiating the legal proceedings, while Optum, Inc. and potentially other unnamed defendants are listed as respondents. Optum is a well-known health services and innovation company that provides a wide range of services to the healthcare industry.

The filing of a civil lawsuit at the federal level typically indicates a dispute concerning federal law, interstate commerce, or significant financial matters. As the case progresses, further filings and court orders will likely shed light on the precise issues at the heart of this legal action.

This development marks the beginning of a new judicial process in the District of Maryland, and interested parties will be following its progression through the court system. Updates regarding the case will be made available through public records as they become accessible.


25-079 – Healthcare Living for Families, Inc. v. Optum, Inc. et al


AI has delivered the news.

The answer to the following question is obtained from Google Gemini.


govinfo.gov District CourtDistrict of Maryland published ’25-079 – Healthcare Living for Families, Inc. v. Optum, Inc. et al’ at 2025-08-09 23:39. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.

Leave a Comment